InflaRx, a company based in Germany, maintains offices and subsidiaries in Jena, Munich, and Ann Arbor.
4 reports, 2 independent
Updated Aug 21
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 4
- Developments
- 1
- Repetition
- 75%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
InflaRx, a company based in Germany, maintains offices and subsidiaries in Jena, Munich, and Ann Arbor.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Inflarx (Germany)
company in Jena, Germany
Nothing else this week.
-
Jena
city in Thuringia, Germany
-
Munich
capital and most populous city of Bavaria, Germany
-
Ann Arbor
county seat of Washtenaw County, Michigan, United States
Related events
Coverage
Newest first; wire copies grouped- GlobeNewswireInflaRx Announces Participation in September Investor Conferences JENA, Germany, Aug. 21, 2025 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammator
- GlobeNewswireInflaRx Reports Second Quarter 2025 Financial Results and Provides Business Update INF904 Phase 2a data in chronic spontaneous urticaria (CSU) and hidradenitis suppurativa (HS) expected by the end of
- ZacksInflaRx N.V. (IFRX) Reports Q2 Loss, Misses Revenue Estimates InflaRx N.V. (IFRX) came out with a quarterly loss of $0.24 per share in line with the Zacks Consensus Estimate. This compares to a loss
- GlobeNewswireInflaRx to Report Second Quarter 2025 Results on August 7, 2025 JENA, Germany, July 31, 2025 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory